# Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

> **NCT06411223** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Yale University** · enrollment: 50 (actual)

## Conditions studied

- Hiv

## Interventions

- **BEHAVIORAL:** Collaborative drug therapy management model
- **DRUG:** Cabotegravir/Rilpivirine

## Key facts

- **NCT ID:** NCT06411223
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06411223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06411223, "Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06411223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*